Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
amgen kras 510 approval | 1.72 | 0.1 | 5718 | 67 | 23 |
amgen | 1.2 | 0.2 | 9390 | 78 | 5 |
kras | 1.3 | 0.4 | 9787 | 4 | 4 |
510 | 1.17 | 0.7 | 4788 | 79 | 3 |
approval | 0.99 | 0.5 | 678 | 70 | 8 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
amgen kras g12c fda approval | 0.12 | 0.9 | 4377 | 56 |
kras g12c amg 510 | 1.64 | 0.8 | 1949 | 83 |
amg 510 fda approval | 1.48 | 0.3 | 7198 | 72 |
fda 510 k approval | 1.83 | 0.2 | 9185 | 25 |
fda 510 k approval process | 1.26 | 0.2 | 5445 | 70 |
the clinical kras g12c inhibitor amg 510 | 1.78 | 0.6 | 7853 | 56 |
kras g12c inhibitor amgen | 0.68 | 0.2 | 2016 | 86 |
what is kras g12c | 1.62 | 0.3 | 8059 | 23 |
kras g12c inhibitor 1 | 0.67 | 0.8 | 7160 | 64 |
kras g12c inhibitor adagrasib | 0.63 | 0.7 | 5518 | 80 |
kras g12c inhibitor-12 | 0.69 | 0.8 | 7965 | 57 |
kras g12c on inhibitor | 0.73 | 0.7 | 211 | 34 |
kras g12c inhibitor fda approval | 1.95 | 0.9 | 7666 | 10 |
kras g12c-in-3 | 0.13 | 0.7 | 6205 | 82 |
kras g12c inhibitor-12_1855 | 1.25 | 0.3 | 4549 | 92 |
kras g12d inhibitor amgen | 1.71 | 0.9 | 1244 | 40 |
kras g12c inhibitor resistance | 0.81 | 0.6 | 5048 | 75 |
kras g12c inhibitor drugs | 1.19 | 0.1 | 2802 | 76 |
kras p.g12v | 1.34 | 1 | 9558 | 85 |
kras-g12 | 0.24 | 0.8 | 9042 | 78 |
kras g12c competitive with attgraseb drug | 1.25 | 0.1 | 5617 | 91 |
fda approved kras g12c inhibitor | 1.68 | 0.6 | 7372 | 16 |
kras g12d/+ | 1.16 | 0.7 | 4004 | 45 |
kras g12c clinical trial | 0.39 | 0.5 | 4918 | 50 |